NVSEF   $100.42  -0.30% Market Open

NOVARTIS AG BASEL AKT
Total Cash 13.85B
totalCashPerShare 6.928
EBITDA 20.89B
Total Debt 32.16B
quickRatio 0.782
currentRatio 1.111
Total Revenue 49.94B
debtToEquity 74.029
Revenue/Share 24.543
ROA 0.09575
ROE 0.28786
grossProfits
freeCashflow 6.24B
operatingCashflow 15.97B
earningsGrowth 0.85
revenueGrowth 0.089
grossMargins 0.75825
ebitdaMargins 0.41838002
operatingMargins 0.33738
profitMargins 0.35248002
enterpriseValue 230.67B
forwardPE
floatShares 1.91B
sharesOutstanding 2.00B
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.04%
heldPercentInstitutions 0.39%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 21.666
Price To Book help_outline 4.90
earningsQuarterlyGrowth 0.81
netIncomeToCommon 11.76B
trailingEps 5.73%
forwardEps
enterpriseToEbitda 11.04
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 958
lastUpdated Nov. 7, 2024, 1:29 a.m.